11β-hydroxypregnenolone
11β-hydroxypregnenolone has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 21, 2026: “Binding of a Novel 11β-Hydroxysteroid to the Apelin Receptor (APLNR) and Its Possible Role in Regulating Skeletal Muscle Health in Mice”.
1 paper studies it2 findingsUpdated
1 new paper in 30 daysSee all 1 papers on 11β-hydroxypregnenolone
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Cells1
What did studies of 11β-hydroxypregnenolone find?
1Studies of 11β-hydroxypregnenolone measured one outcome, myoblast differentiation.
Myoblast differentiation
upin mouse cells1
1 study
Myoblast differentiation
upin mouse cells1
11β-hydroxypregnenolone increases myoblast differentiation in mouse cells (acting through APLNR).
“11β-OHP5, acting through APLNR, positively affects myoblast differentiation”
Cellsacting through APLNRC2C12 myoblast
International journal of molecular sciences
What is 11β-hydroxypregnenolone linked with?
1Studies link 11β-hydroxypregnenolone with APLNR.
APLNR
upin silico1
1 study
APLNR
upin silico1
11β-hydroxypregnenolone is associated with APLNR in silico.
“We show that 11β-OHP5 interacts with APLNR”
In silico
International journal of molecular sciences